WFAG
AMPE

Wescott Financial Advisory Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Wescott Financial Advisory Group’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-68
Closed -$1K – 160
2022
Q3 		$1K Hold
68
– – ﹤0.01% 139
2022
Q2 		$3K Hold
68
– – ﹤0.01% 131
2022
Q1 		$10K Hold
68
– – ﹤0.01% 128
2021
Q4 		$12K Hold
68
– – 0.01% 72
2021
Q3 		$34K Hold
68
– – 0.02% 69
2021
Q2 		$29K Hold
68
– – 0.02% 65
2021
Q1 		$35K Hold
68
– – 0.02% 62
2020
Q4 		$33K Buy
+68
New +$22.3K 0.02% 59

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Wescott Financial Advisory Group's AMPE Position: Q4 2022 in Review

Wescott Financial Advisory Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 68 shares — an estimated $1K sold.

Wescott Financial Advisory Group first reported a position in AMPE in Q4 2020 and held it in 8 quarters. The position peaked at $35K in Q1 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Wescott Financial Advisory Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Wescott Financial Advisory Group sold 68 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $1K.
  • Wescott Financial Advisory Group first reported a position in Ampio Pharmaceuticals Inc. in Q4 2020 and held it in 8 quarters.
  • Wescott Financial Advisory Group's Ampio Pharmaceuticals Inc. position peaked at $35K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Wescott Financial Advisory Group's 13F filing for Q4 2022, filed 6 Feb 2023.